Literature DB >> 8245672

CCK-8 and gastrin plasma levels in cholecystectomized and colorectal cancer patients.

M A Rogy1, E Kovats, G Koss, M Müller, R Függer, R Steininger, E Pilz, R Rauhs, A Fritsch.   

Abstract

The elevated incidence of large bowel carcinoma after cholecystectomy has long been controversial. The pathomechanism of this entity, however, is still unclear. Many authors have demonstrated a correlation between cholecystokinin (CCK) and gastrin levels and the occurrence of colorectal cancer. As yet, no clear data are available on the potential impact of cholecystectomy on CCK level alterations. Moreover, no reports have yet been published on CCK receptors. We have investigated the role of CCK-8 and gastrin plasma levels in patients with prior cholecystectomy and CCK receptor levels in patients with colorectal cancer. 125 patients entered a prospective study. Of these, 45 served as controls. 40 patients had prior cholecystectomy, 5 patients underwent cholecystectomy during the ongoing trial. 35 patients had a colorectal cancer, 5 of these had prior cholecystectomy. No patient had elevated CCK-8 plasma levels. Gastrin levels were slightly elevated in 2 patients. There was no correlation between large bowel carcinoma and CCK-8 and gastrin levels. Elevated CCK-8 levels following cholecystectomy occur neither immediately after surgery nor on a long-term basis. Immunohistochemical studies in patients with colorectal cancer showed no CCK receptors in the normal colonic or tumor tissue. These findings are contrary to gastrin receptor data.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8245672     DOI: 10.1007/bf00341190

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN: 0179-1958            Impact factor:   2.571


  23 in total

Review 1.  Cholecystectomy and colorectal cancer.

Authors:  R J Moorehead; S T McKelvey
Journal:  Br J Surg       Date:  1989-03       Impact factor: 6.939

Review 2.  Hormonal control of gastric and colorectal cancer in man.

Authors:  D L Morris; S A Watson; L G Durrant; J D Harrison
Journal:  Gut       Date:  1989-04       Impact factor: 23.059

3.  Clinical significance of gastrin receptors in human colon cancers.

Authors:  J R Upp; P Singh; C M Townsend; J C Thompson
Journal:  Cancer Res       Date:  1989-01-15       Impact factor: 12.701

4.  Cholecystokinin bioactivity in human plasma. Molecular forms, responses to feeding, and relationship to gallbladder contraction.

Authors:  R A Liddle; I D Goldfine; M S Rosen; R A Taplitz; J A Williams
Journal:  J Clin Invest       Date:  1985-04       Impact factor: 14.808

5.  The in vitro growth response of primary human colorectal and gastric cancer cells to gastrin.

Authors:  S A Watson; L G Durrant; J D Crosbie; D L Morris
Journal:  Int J Cancer       Date:  1989-04-15       Impact factor: 7.396

6.  Cancer incidence after cholecystectomy--a cohort study with 30 years follow-up.

Authors:  S Gudmundsson; T R Möller; H Olsson
Journal:  Eur J Surg Oncol       Date:  1989-04       Impact factor: 4.424

7.  Lack of relationship between cholecystectomy and colorectal cancer. A case control autopsy study in a defined population.

Authors:  S G Eriksson; C G Lindström
Journal:  Scand J Gastroenterol       Date:  1984-10       Impact factor: 2.423

8.  Unaltered risk of colorectal cancer within 14-17 years of cholecystectomy: updating of a population-based cohort study.

Authors:  H O Adami; U B Krusemo; O Meirik
Journal:  Br J Surg       Date:  1987-08       Impact factor: 6.939

9.  The absence of a relationship between cholecystectomy and the subsequent occurrence of cancer of the proximal colon.

Authors:  J S Abrams; J R Anton; D C Dreyfuss
Journal:  Dis Colon Rectum       Date:  1983-03       Impact factor: 4.585

10.  Growth of colorectal carcinoma cells: regulation in vitro by gastrin, pentagastrin and the gastrin-receptor antagonist proglumide.

Authors:  A Imdahl; S Eggstein; C Crone; E H Farthmann
Journal:  J Cancer Res Clin Oncol       Date:  1989       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.